0.00Open0.03Pre Close0 Volume293 Open Interest2.50Strike Price0.00Turnover4265.37%IV51.47%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-3DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.0297Delta0.0304Gamma169.67Leverage Ratio-1.9105Theta0.0000Rho-5.04Eff Leverage0.0000Vega
Applied Therapeutics Stock Discussion
$Applied Therapeutics(APLT.US)$
The biopharmaceutical company said Thursday that the Food and Drug Administration now has a target action date of Nov. 28 for its application, compared with the previous date of Aug. 28.
The company's application is for govorestat in the treatment of Galactosemia, a rare genetic condition that makes patients unable to metab...
In a significant development for the healthcare sector and investors worldwide, Applied Therapeutics Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, has announced the Food and Drug Administration's acceptance and priority review of t...
No comment yet